Wound News and Research

RSS

Amphibian skin secretions can reveal amazing medicinal properties

Frogs place in culture ranges from the wise, to the prince in disguise. But it's the idea that a frog can produce life-saving medicine that's currently the subject of an international research project involving Professor Chris Shaw and colleagues at Queen's University Belfast, in Northern Ireland. They have discovered proteins in frog skins that could be used to treat cancer, diabetes, strokes and transplant patients by regulating the growth of blood vessels.

17 Aug 2011

Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has completed patient recruitment in a clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.

17 Aug 2011

Enrollment commences in RegeneRx RGN-259 Phase 2 trial for dry eye syndrome

RegeneRx Biopharmaceuticals, Inc. has announced that the first patients have been enrolled and randomized to receive RGN-259 or placebo in its 72-patient, Phase 2 clinical trial in patients with dry eye syndrome.

16 Aug 2011

Misonix adds MD Solutions to distribution network in Asia and the South Pacific

Misonix, Inc., a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide has entered into a new three-year exclusive distribution agreement with MD Solutions Australasia Pty. Ltd., based in Newport, Victoria, Australia.

12 Aug 2011

Renewed focus on veterans' coverage gap

From the critical moments after she suffered a gunshot wound to the head in January to her triumphant return to Congress last week for a vote on the debt-limit deal, Rep. Gabrielle Giffords owes her recovery in no small part to veterans with similar injuries.

12 Aug 2011

NSAIDs like ibuprofen slow the spread of breast cancers

Published online on Aug. 7, 2011, the journal Nature Medicine reports that non-steroidal anti-inflammatory drugs including ibuprofen reduce the severity of postpartum breast cancers in animal models.

12 Aug 2011

Researchers develop epidermal electronic system

Through a combination of careful theoretical modeling and precise micro-manufacturing, a team of engineers and scientists has developed a new type of ultra-thin, self-adhesive electronics device that can effectively measure data about the human heart, brain waves and muscle activity - all without the use of bulky equipment, conductive fluids, or glues.

12 Aug 2011

SANUWAVE second quarter revenues increase 40%

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today reported financial results for the three and six months ended June 30, 2011 and provided a business update.

10 Aug 2011

Covalon to showcase latest line of innovative wound care and coating products at FIME Expo

Covalon Technologies Ltd., an advanced medical technologies company, today announced it is presenting its latest line of advanced wound care and medical coating products, including ColActive® Plus Ag from August 10th to 12th at FIME International Medical Expo.

8 Aug 2011

Study: miR-200s play a paradoxical role in metastatic cancer development

While they may be small in size, a family of tiny molecules called microRNAs could potentially play a large role in the process of cancer metastasis, or the spread of cancer from one area of the body to another.

8 Aug 2011

Osiris second quarter revenues increase to $10.4 million

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory and cardiovascular disease areas and wound healing, announced today its results for the second quarter ended June 30, 2011.

5 Aug 2011

Dermatologist discusses common skin conditions that affect people of color at AAD 2011 meeting

The U.S. Census Bureau predicts that by the year 2050, more than half the U.S. population will have skin of color. Recognizing this trend, dermatologists are educating the public about the different ways that common skin conditions appear in various skin tones.

5 Aug 2011

Key protein discoveries could lead to new lung repair therapies for children, adults

A team at The Saban Research Institute of Children's Hospital Los Angeles has made crucial discoveries about the role of key proteins in wound healing in the tiny air sacs in the lungs known as "alveoli" that could lead to new therapies for children and adults.

5 Aug 2011

SWHR congressional briefing highlights health issues facing women veterans today

The physical and mental health problems affecting women veterans are a major issue within the Department of Veterans Affairs (VA) and the Department of Defense, and the catalyst for the Society for Women's Health Research (SWHR) congressional briefing, Women Veteran's Health: Sexx Matters held on Tuesday, August 2.

4 Aug 2011

New investment to strengthen Clearbridge Accelerator's incubation platform

Clearbridge Accelerator announced today that it has received an investment from Tim Draper, a well-established venture capitalist based in the Silicon Valley.

2 Aug 2011

FDA clears Derma Sciences' MEDIHONEY Hydrogel Wound and Burn Dressing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has received U.S. Food and Drug Administration 510(k) clearance for its patented MEDIHONEY Hydrogel Wound and Burn Dressing with Leptospermum honey.

2 Aug 2011

'Systems biology' study of breast cancer

Using a "systems biology" approach - which focuses on understanding the complex relationships between biological systems - to look under the hood of an aggressive form of breast cancer, researchers for the first time have identified a set of proteins in the blood that change in abundance long before the cancer is clinically detectable.

29 Jul 2011

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

RegeneRx Biopharmaceuticals, Inc. has announced that it is set to begin a Phase 2 clinical trial in 72 patients with dry eye syndrome.

29 Jul 2011

TMS rolls out MUNI for law enforcement and other government agencies

Total Medical Solutions (TMS), specializing in complex care for workers' compensation, has rolled out MUNI for municipalities, law enforcement and other government agencies.

27 Jul 2011

Cocaine-free topical anaesthetics can effectively treat pain caused by torn skin

While some pain killers need to be injected into the damaged tissue in order to work, topical anaesthetics only need to be spread on the surface. The earliest examples of "topical" anaesthetics contained cocaine, but now a new systematic review has shown that newer agents that don't contain cocaine can effectively treat pain caused by torn skin.

27 Jul 2011